Related Experiment Video
Updated: Jan 5, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
Flow Cytometric, Morphologic, and Laboratory Comparative Study in Patients With Leukocytosis and Cytopenia
Estafani Rivas1, Fred V Plapp1, Wei Cui1
1University of Kansas Medical Center, Kansas City.
Insights
Flow cytometry immunophenotyping (FCI) is not effective for screening patients with leukocytosis or cytopenia. Peripheral blood smear morphology is a more accurate and cost-effective screening method.
Area of Science:
- Hematology
- Clinical Pathology
Background:
- Flow cytometry immunophenotyping (FCI) and peripheral blood smear (PBS) morphology are diagnostic tools in hematology.
- Evaluating the utility of FCI as a primary screening method for hematologic conditions is crucial.
Purpose of the Study:
- To assess the effectiveness of FCI as a screening test for patients presenting with leukocytosis and cytopenia.
- To compare the diagnostic yield of FCI with PBS morphology in this patient cohort.
Main Methods:
- A retrospective analysis of 320 patients was conducted between August 2016 and December 2016.
- Both FCI and PBS morphology were evaluated for all identified patients.
- Patient indications for FCI, including history of hematologic malignancy (HHM), leukocytosis, and cytopenia, were recorded.
Main Results:
- The positive FCI rate was low (4.4%–12.5%) in patients with absolute neutrophilia, especially when circulating blasts were excluded.
- Patients with absolute lymphocytosis demonstrated a high positive FCI rate (93%).
- Patients with HHM and pancytopenia had a higher incidence of positive FCI findings compared to those without HHM and with isolated cytopenia. PBS morphology showed a strong correlation with FCI (P = .0001).
Conclusions:
- Peripheral blood smear evaluation is an accurate and cost-effective screening test for hematologic abnormalities.
- Flow cytometry immunophenotyping has a very low diagnostic yield for patients with mature neutrophilia and isolated cytopenia.
Objectives:
We wanted to evaluate the effectiveness of flow cytometry immunophenotyping (FCI) as a screening test for patients with leukocytosis and cytopenia.
Methods:
We identified 320 patients during August 2016 to December 2016 and evaluated FCI and morphology of peripheral blood smears (PBSs).
Results:
The most common indications for FCI included history of hematologic malignancy (HHM, n = 126), leukocytosis (n = 80), and cytopenia (n = 53). Positive FCI rate was low with a range of 4.4% to 12.5% in patients with absolute neutrophilia regardless of HHM, if cases with circulating blasts were excluded. Patients with absolute lymphocytosis had a 93% positive FCI rate. Patients with HHM and pancytopenia showed a higher incidence of positive FCI findings than patients without HHM and with isolated cytopenia. PBS morphology correlated strongly with FCI (P = .0001).
Conclusion:
PBS evaluation is an accurate and cost-effective screening test. FCI for patients with mature neutrophilia and isolated cytopenia has a very low yield.
More Related Videos
12:05Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
Related Concept Videos
Flow Cytometry
In...
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...